Intravenous Immunoglobulin (IVIg) Market Report

Intravenous Immunoglobulin (IVIg) Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jun 08, 2020
  • PAGES：225
  • REPORT CODE：GMM539070
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.

    The worldwide Intravenous Immunoglobulin (IVIg) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period.

    This report presents the market size and development trends by detailing the Intravenous Immunoglobulin (IVIg) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Intravenous Immunoglobulin (IVIg) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Intravenous Immunoglobulin (IVIg) industry and will help you to build a panoramic view of the industrial development.

    Intravenous Immunoglobulin (IVIg) Market, By Type:

    • IVIg Liquid

    • IVIg Powder

    Intravenous Immunoglobulin (IVIg) Market, By Application:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    Some of the leading players are as follows:

    • Kedrion

    • CBPO

    • CSL

    • Hualan Bio

    • LFB Group

    • Sichuan Yuanda Shuyang

    • Baxter

    • BPL

    • Shanghai RAAS

    • CNBG

    • Grifols

    • Biotest

    • Octapharma

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Immunoglobulin (IVIg) Market

    • 1.3 Market Segment by Type

      • 1.3.1 IVIg Liquid

      • 1.3.2 IVIg Powder

    • 1.4 Market Segment by Application

      • 1.4.1 Immunodeficiency

      • 1.4.2 Autoimmune Disease

      • 1.4.3 Acute Infection

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Intravenous Immunoglobulin (IVIg) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major Types

      • 3.4.1 IVIg Liquid

      • 3.4.2 IVIg Powder

    4 Segmentation of Intravenous Immunoglobulin (IVIg) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major End-Users

      • 4.4.1 Immunodeficiency

      • 4.4.2 Autoimmune Disease

      • 4.4.3 Acute Infection

    5 Market Analysis by Major Regions

    • 5.1 Global Intravenous Immunoglobulin (IVIg) Production Analysis by Top Regions

    • 5.2 Global Intravenous Immunoglobulin (IVIg) Consumption Analysis by Top Regions

    • 5.3 Global Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Intravenous Immunoglobulin (IVIg) Market among Top Countries

    • 6.1 Top 5 Export Countries in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 7.1 North America Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 7.1.1 United States Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 7.1.2 Canada Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 7.1.3 Mexico Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    8. Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 8.1 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 8.2 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 8.3 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 8.3.1 Germany Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.2 UK Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.3 France Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.4 Italy Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.5 Spain Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.6 Belgium Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.7 Poland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.8 Russia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.9 Turkey Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.10 Netherlands Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.11 Portugal Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.12 Denmark Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.13 Finland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.14 Iceland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.15 Norway Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.16 Sweden Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 9.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 9.1.1 China Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.1.2 Japan Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.1.4 India Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.1.5 ASEAN Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.1.6 South Korea Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    10 LAMEA Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 10.1 LAMEA Intravenous Immunoglobulin (IVIg) Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.1.2 Brazil Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.1.3 North Africa Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.1.4 South Africa Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.1.5 Argentina Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Kedrion

      • 11.1.1 Kedrion Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 CBPO

      • 11.2.1 CBPO Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 CSL

      • 11.3.1 CSL Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Hualan Bio

      • 11.4.1 Hualan Bio Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 LFB Group

      • 11.5.1 LFB Group Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Sichuan Yuanda Shuyang

      • 11.6.1 Sichuan Yuanda Shuyang Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Baxter

      • 11.7.1 Baxter Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 BPL

      • 11.8.1 BPL Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Shanghai RAAS

      • 11.9.1 Shanghai RAAS Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 CNBG

      • 11.10.1 CNBG Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Grifols

      • 11.11.1 Grifols Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Biotest

      • 11.12.1 Biotest Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Octapharma

      • 11.13.1 Octapharma Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 93 Figures and 158 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of IVIg Liquid

    • Figure Market Size and Growth Rate of IVIg Powder

    • Figure Market Size and Growth Rate of Immunodeficiency

    • Figure Market Size and Growth Rate of Autoimmune Disease

    • Figure Market Size and Growth Rate of Acute Infection

    • Figure North America Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure United States Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure France Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure China Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure India Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Intravenous Immunoglobulin (IVIg) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Intravenous Immunoglobulin (IVIg)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different Types from 2014 to 2026

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of IVIg Liquid

    • Figure Market Size and Growth Rate of IVIg Powder

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Immunodeficiency

    • Figure Market Size and Growth Rate of Autoimmune Disease

    • Figure Market Size and Growth Rate of Acute Infection

    • Table Global Intravenous Immunoglobulin (IVIg) Production by Major Regions

    • Table Global Intravenous Immunoglobulin (IVIg) Production Share by Major Regions

    • Table Global Intravenous Immunoglobulin (IVIg) Consumption by Major Regions

    • Table Global Intravenous Immunoglobulin (IVIg) Consumption Share by Major Regions

    • Table North America Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table LAMEA Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Intravenous Immunoglobulin (IVIg) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2014

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2018

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2026

    • Figure United States Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by Types from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure China Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion

    • Figure Sales and Growth Rate Analysis of Kedrion

    • Figure Revenue and Market Share Analysis of Kedrion

    • Table Product and Service Introduction of Kedrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CBPO

    • Figure Sales and Growth Rate Analysis of CBPO

    • Figure Revenue and Market Share Analysis of CBPO

    • Table Product and Service Introduction of CBPO

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio

    • Figure Sales and Growth Rate Analysis of Hualan Bio

    • Figure Revenue and Market Share Analysis of Hualan Bio

    • Table Product and Service Introduction of Hualan Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB Group

    • Figure Sales and Growth Rate Analysis of LFB Group

    • Figure Revenue and Market Share Analysis of LFB Group

    • Table Product and Service Introduction of LFB Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sichuan Yuanda Shuyang

    • Figure Sales and Growth Rate Analysis of Sichuan Yuanda Shuyang

    • Figure Revenue and Market Share Analysis of Sichuan Yuanda Shuyang

    • Table Product and Service Introduction of Sichuan Yuanda Shuyang

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BPL

    • Figure Sales and Growth Rate Analysis of BPL

    • Figure Revenue and Market Share Analysis of BPL

    • Table Product and Service Introduction of BPL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai RAAS

    • Figure Sales and Growth Rate Analysis of Shanghai RAAS

    • Figure Revenue and Market Share Analysis of Shanghai RAAS

    • Table Product and Service Introduction of Shanghai RAAS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CNBG

    • Figure Sales and Growth Rate Analysis of CNBG

    • Figure Revenue and Market Share Analysis of CNBG

    • Table Product and Service Introduction of CNBG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest

    • Figure Sales and Growth Rate Analysis of Biotest

    • Figure Revenue and Market Share Analysis of Biotest

    • Table Product and Service Introduction of Biotest

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma

    • Figure Sales and Growth Rate Analysis of Octapharma

    • Figure Revenue and Market Share Analysis of Octapharma

    • Table Product and Service Introduction of Octapharma

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US